Bruce Jackson Analyst PerformanceEquity Research Analyst at BenchmarkBruce Jackson is a stock analyst at Benchmark focused in the medical sector, covering 19 publicly traded companies. Over the past year, Bruce Jackson has issued 8 stock ratings, including strong buy, buy, and hold recommendations. While full access to Bruce Jackson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Bruce Jackson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings43 Last 11 YearsBuy Recommendations83.72% 36 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution43RatingsDistribution of strong buy, buy, hold, and sell ratings by Bruce Jackson.RatingPercentageCount Strong Buy2.3%1 ratings Buy81.4%35 ratings Hold16.3%7 ratings Sell0.0%0 ratingsOut of 43 total stock ratings issued by Bruce Jackson at Benchmark, the majority (81.4%) have been Buy recommendations, followed by 16.3% Hold and 2.3% Strong Buy.Best & Worst CallsBest Call0000.0%CLNNMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%MDXGDec 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ89.5% of companies on NASDAQ17 companiesNYSE10.5% of companies on NYSE2 companiesBruce Jackson, an analyst at Benchmark, currently covers 19 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical16 companies84.2%Manufacturing2 companies10.5%Computer and Technology1 company5.3%Bruce Jackson of Benchmark specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Computer and Technology companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE8 companies42.1%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES2 companies10.5%MED INSTRUMENTS2 companies10.5%MED PRODUCTS1 company5.3%INSTRU - SCIENTFC1 company5.3%MEDICAL LABORATORIES1 company5.3%MEDICAL SERVICES1 company5.3%MED/DENTAL - SUPP1 company5.3%MED - DRUGS1 company5.3%MEDICAL INFO SYS1 company5.3% About Bruce JacksonBruce Jackson is an Equity Research Analyst focused on Healthcare Technology companies that improve patient outcomes while lowering the total cost of care. He’s been named a Wall Street Journal All-Star for stock picking in Health Equipment & Supplies and received the FT/StarMine Analyst Award for Number 1 stock picker in Health Care Equipment and Supplies. Bruce began his Wall Street career at Vector Securities and has held Senior analyst positions at Wachovia, RBC, and Morgan Joseph TriArtisan. Before Wall Street, he worked at Abbott Laboratories in their Hospital Products and Diagnostics Divisions. Bruce is a graduate of the University of Wisconsin, holds an MBA from the Johnson Graduate School of Management at Cornell University, and was recently awarded a Masters in Data Science from the University of St. Thomas.Follow on LinkedIn Bruce Jackson's Ratings History at Benchmark Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMMEDMiniMed Group5/12/2026Initiated Coverage$11.16$20.00Buy$0.0000.00% ROITNDMTandem Diabetes Care5/11/2026Initiated Coverage$14.77Hold$0.0000.00% ROIMMEDMiniMed Group5/11/2026Upgrade$11.89Strong-Buy$0.0000.00% ROINEONeoGenomics4/29/2026Upgrade$9.02$11.00Buy$0.0000.00% ROICVCapsoVision3/27/2026Lower Price Target$7.13$10.00Speculative Buy$0.0000.00% ROICVCapsoVision11/14/2025Reiterated Rating$5.39Speculative Buy$0.0000.00% ROIABTAbbott Laboratories10/10/2025Initiated Coverage$133.24$145.00Buy$0.0000.00% ROICVCapsoVision7/28/2025Initiated Coverage$4.00$5.00Speculative Buy$0.0000.00% ROIBFRIBiofrontera5/19/2025Lower Price Target$0.66$2.75Buy$0.0000.00% ROIHUMAHumacyte5/14/2025Lower Price Target$1.91$14.00Buy$0.0000.00% ROIHBIOHarvard Bioscience5/13/2025Lower Price Target$3.61$30.00Speculative Buy$0.0000.00% ROICLNNClene5/8/2025Lower Price Target$2.66$33.00Buy$0.0000.00% ROIGNLXGenelux5/8/2025Lower Price Target$2.49$23.00Speculative Buy$0.0000.00% ROIBLTEBelite Bio3/26/2025Reiterated Rating$65.18$80.00Buy$000.0000.00% ROIHBIOHarvard Bioscience3/24/2025Lower Price Target$6.50$45.00Speculative Buy$0.0000.00% ROIHUMAHumacyte2/27/2025Reiterated Rating$3.74Buy$0.0000.00% ROIBLTEBelite Bio1/21/2025Boost Price Target$60.05$79.00Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenWells Fargo & CompanyRoyal Bank Of CanadaJefferies Financial GroupThe Goldman Sachs GroupBMO Capital MarketsScotiabankNational Bank FinancialSanford C. BernsteinGuggenheimATB Cormark Capital MarketsTDOddo BhfCICC ResearchScotia Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
